Extraintestinal Manifestations of Inflammatory Bowel Disease: A Focus on Kidney Complications
International Journal of Molecular Sciences · 21.05.2026 · 27 (10) · 4614
DOI: 10.3390/ijms27104614 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.05.2026. Verfasst von Hao Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Xiangya Hospital, Central South University, Changsha 410008, China. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Kidney Diseases. Die Arbeit nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Xiangya Hospital Central South University, Youth Science Foundation of Xiangya Hospital.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD), comprising Crohn’s disease (CD) and ulcerative colitis (UC), is a chronic relapsing–remitting condition characterized by systemic and intestinal inflammation and immune dysregulation. Up to 47% of IBD patients develop extraintestinal manifestations, yet kidney and urological involvement remain underrecognized. Accumulating evidence has linked IBD to nephrolithiasis, glomerular diseases, tubulointerstitial nephritis, acute kidney injury, chronic kidney disease, and, rarely, amyloid A amyloidosis. Population studies have consistently shown elevated risks for various important kidney disorders in IBD, with CD generally posing a greater risk than UC. The pathogenesis of kidney complications in IBD reflects complex gut–kidney interactions, including metabolic and absorptive abnormalities, shared genetic and immune pathways, intestinal dysbiosis with nephrotoxic microbial metabolites, systemic inflammation, and drug-related nephrotoxicity. Strategies for kidney protection in IBD include increased awareness, close monitoring of kidney function, urinary metabolic profiling in high-risk patients, and prompt nephrology referral for early detection and treatment. Management should include an effective and sustained control of intestinal inflammation, discontinuation of potential nephrotoxic drugs when indicated, and timely diagnosis and treatment of kidney manifestations, as well as integrating kidney complications into IBD guidelines to enhance awareness, ultimately optimizing both the kidney and overall outcomes for IBD patients. Future studies are needed to validate the potential predictive biomarkers for kidney complications and to develop targeted interventions to address shared gut–kidney pathogenic mechanisms in IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Xiangya Hospital, Central South University, Changsha 410008, China.
- Division of Cardiovascular Medicine, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198-3040, USA.
ORCID-Profile: Hao Wu, Aiping Lin, Hong Hao
Förderung
- Xiangya Hospital Central South University
- Youth Science Foundation of Xiangya Hospital
Zitieren
APA
Wu, H., Lin, A., Chi, J., Zhang, J., Peng, B., Ni, D., Hao, H., & Liu, Z. (2026). Extraintestinal Manifestations of Inflammatory Bowel Disease: A Focus on Kidney Complications. International Journal of Molecular Sciences, 27(10), 4614. https://doi.org/10.3390/ijms27104614
Vancouver
Wu H, Lin A, Chi J, Zhang J, Peng B, Ni D, et al. Extraintestinal Manifestations of Inflammatory Bowel Disease: A Focus on Kidney Complications. International Journal of Molecular Sciences. 2026;27(10):4614. doi:10.3390/ijms27104614
BibTeX
@article{Wu2026,
author = {Wu, Hao and Lin, Aiping and Chi, Jingshu and Zhang, Jing and Peng, Bo and Ni, Dan and Hao, Hong and Liu, Zhenguo},
title = {Extraintestinal Manifestations of Inflammatory Bowel Disease: A Focus on Kidney Complications},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {10},
pages = {4614},
doi = {10.3390/ijms27104614}
}
EUVIMED